RARE
#1718
Ultragenyx Pharmaceutical Inc. - Common Stock
30.2 1 USD
-0.05%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.73%
Monthly Change
+20.41%
6 month change
+36.57%
Year Change
+10.42%
Previous Close
31.7 1
Open
30.0 6
Low
29.8 3
High
30.2 3
Volume
1 137
Financials
- Market Capitalization 2.98 B
- Employee 1 371
- Founded 2010
- CEO Emil Kakkis
- Website www.ultragenyx.com
- Headquarter Delaware, United States
- FIGI BBG001RWPDW6
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.43
Price to sales ratio
3.1
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1666 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 35.92 USD | -2.23% | -3.65% | +16.70% | +10.25% | 3.16 B USD | ||
| 1684 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 50.85 USD | -4.35% | -2.55% | +19.51% | +146.13% | 3.10 B USD | ||
| 1737 |  BEAM Beam Therapeutics Inc. - Common Stock | 28.38 USD | -7.98% | -20.77% | -8.60% | +41.05% | 2.92 B USD | ||
| 1763 |  IRON Disc Medicine, Inc. - Common Stock | 73.45 USD | -3.38% | -6.95% | +4.75% | +27.92% | 2.81 B USD |
Frequently asked questions about Ultragenyx Pharmaceutical Inc. - Common Stock
What is the Ultragenyx Pharmaceutical Inc. - Common Stock stock price today?
The current price of Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) is 30.21. Over the past 24 hours, the stock has changed by -4.73%. Follow the RARE chart for real-time price dynamics.
What is the stock ticker of Ultragenyx Pharmaceutical Inc. - Common Stock?
Ultragenyx Pharmaceutical Inc. - Common Stock trades under the ticker RARE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Ultragenyx Pharmaceutical Inc. - Common Stock stock going up?
RARE has changed by -12.71% over the last week, +20.41% over the last month, and +10.42% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Ultragenyx Pharmaceutical Inc. - Common Stock net income for the last quarter?
Ultragenyx Pharmaceutical Inc. - Common Stock reported net income of -185 M for the last quarter. The previous quarter showed -128.64 M, which means net income changed by -43.82%.
How many employees does Ultragenyx Pharmaceutical Inc. - Common Stock have?
As of the latest available data, Ultragenyx Pharmaceutical Inc. - Common Stock has 1 371 employees. Workforce size can provide additional context about the company's scale and operations.
What is Ultragenyx Pharmaceutical Inc. - Common Stock EBITDA?
Ultragenyx Pharmaceutical Inc. - Common Stock EBITDA is -131 M, and its EBITDA margin is -96.32%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Ultragenyx Pharmaceutical Inc. - Common Stock stock?
You can buy Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Ultragenyx Pharmaceutical Inc. - Common Stock stock?
Investing in Ultragenyx Pharmaceutical Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RARE chart and related analysis on metatrader.com as part of your research.